Bridging the autonomic divide: Closed-loop spinal cord stimulation as a dynamic therapy for parkinsonian orthostatic hypotension

Neurogenic orthostatic hypotension (nOH) in Parkinson’s disease (PD) represents a potential “central-peripheral disconnection” rather than an isolated peripheral deficit. Driven by progressive sympathetic denervation, this uncoupling leaves the peripheral effectors in a fragile, “sick-but-not-dead” state, while simultaneously exposing the central nervous system (CNS) to recurrent hypoperfusion and aberrant central network reorganization. Current static pharmacological therapies fail to accommodate dynamic postural demands, frequently exacerbate supine hypertension (SH), and impose continuous metabolic strain on already compromised peripheral nerves. We hypothesized that closed-loop spinal cord stimulation (SCS) may emerge as a dynamic neuroprosthetic bridge. By providing posture-responsive subthreshold facilitation to residual sympathetic nerves, closed-loop SCS may restore orthostatic hemodynamics without exacerbating SH. This intermittent, on-demand stimulation theoretically provides essential “metabolic unloading” to vulnerable peripheral fibers, avoiding the continuous overdrive inherent to static therapies. Concurrently, by stabilizing systemic blood pressure, it has the potential to act as a hemodynamic shield, protecting the already vulnerable brain from the secondary ischemic hits that may contribute to cognitive decline. To bridge the translational gap between experimental physiology and clinical deployment, we propose a multidimensional candidacy matrix, incorporating hemodynamic, morphological, and functional reserve testing, to systematically identify optimal candidates for this intervention. By stabilizing peripheral hemodynamics and alleviating the allostatic burden on central networks, closed-loop SCS may transcend static symptomatic relief, offering a comprehensive strategy for dynamic physiological restoration and systemic neuroprotection.